Life Healthcare Group Holdings Ltd. announced unaudited consolidated earnings results for the six months ended March 31, 2018. For the period, the company reported revenue of ZAR 11,323 million compared to ZAR 9,368 million a year ago. Operating profit was ZAR 1,870 million against ZAR 1,790 million a year ago. Profit before tax was ZAR 1,356 million against ZAR 634 million a year ago. Profit after tax attributable to ordinary equity holders of the parent was ZAR 777 million or 54.4 cents per diluted share against ZAR 144 million or 12.7 cents per diluted share a year ago. Headline earnings were ZAR 764 million or 53.5 cents per diluted share against ZAR 281 million or 24.8 cents per diluted share a year ago. Net cash generated from operating activities was ZAR 2,157 million against ZAR 1,468 million a year ago. Capital expenditure was ZAR 882 million against 603 million a year ago. Normalized EBITDA was ZAR 2,673 million against ZAR 2,418 million a year ago. Normalized earnings were ZAR 772 million or 54.2 cents per share against ZAR 590 million or 52.1 cents per share a year ago.

The company's results for the full financial year ending September 30, 2018 are expected to show an increase of at least 20% in EPS (minimum increase of 12.4 cents per share to at least 74.6 cents per share) and at least 20% in HEPS (minimum increase of 15.5 cents per share to at least 92.9 cents per share) from reported EPS and HEPS for the financial year ended September 30, 2017 (EPS: 62.2 cents per share and HEPS: 77.4 cents per share). This is primarily due to the inclusion of Alliance Medical for 12 months (2017: 10.3 months), the nonrecurring impact of the transaction costs as well as the funding costs related to the Alliance Medical acquisition and the impairment of Poland in 2017.